Xia Y - Search Results

1

Target delineation and dose prescription of adaptive replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Xie D, Cheng W, Lv S, Zhong R, Wang L, Hu J, Wang M, Huang S, Su Y, Xia Y. Xie D, et al. Among authors: xia y. Cancer Commun (Lond). 2019 Apr 15;39(1):18. doi: 10.1186/s40880-019-0364-x. Cancer Commun (Lond). 2019. PMID: 30987678 Free PMC article. No abstract available.

2

[Changes of superoxide dismutase (SOD) and metallothionien (MT) before, during, and after radiotherapy for nasopharyngeal carcinoma and their significance].

Su Y, Xia YF, Yang HL, He JH, Wu QL, Zheng Q, Hou JH. Su Y, et al. Among authors: xia yf. Ai Zheng. 2003 Jun;22(6):629-33. Ai Zheng. 2003. PMID: 12948415 Chinese.

3

[Retrospective analysis of 934 nasopharyngeal carcinoma patients treated with conventional external beam radiotherapy alone].

Lu TX, Zhao C, Wu SX, Luo W, Chen Y, Xie FY, Chen M, Zeng XF, Hu WH, Cao XP, Xia YF, Liu XF, Cui NJ. Lu TX, et al. Among authors: xia yf. Zhonghua Zhong Liu Za Zhi. 2005 Oct;27(10):620-2. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 16438874 Chinese.

4

A family-based association study of megsin A23167G polymorphism with susceptibility and progression of IgA nephropathy in a Chinese population.

Xia YF, Huang S, Li X, Yang N, Huang J, Xue C, Zhang M, Leung JC, Lam MF, Li J. Xia YF, et al. Clin Nephrol. 2006 Mar;65(3):153-9. doi: 10.5414/cnp65153. Clin Nephrol. 2006. PMID: 16550745

5

[Clinical study on radiotherapy-related typing of nasopharyngeal carcinoma].

Li ZQ, Xia YF, Liu Q, Liu XF, Han F, Yi W, Luo W, Lu TX. Li ZQ, et al. Zhonghua Yi Xue Za Zhi. 2006 Dec 12;86(46):3272-6. Zhonghua Yi Xue Za Zhi. 2006. PMID: 17313809 Chinese.

6

[Influence of level-Ib lymphadenopathy on the prognosis of nasopharyngeal carcinoma].

Yi W, Liu XM, Xia YF, Liu Q, Li JT. Yi W, et al. Chin J Cancer. 2010 Jan;29(1):87-93. doi: 10.5732/cjc.009.10202. Chin J Cancer. 2010. PMID: 20038317 Free article. Chinese.

7

Continuous fall in hemoglobin level is a poor prognostic factor in patients with nasopharyngeal carcinoma treated with radiotherapy.

Gao J, Hu JY, Xia YF, Yi W, Tao YL, Li G. Gao J, et al. Chin J Cancer. 2010 May;29(5):561-6. doi: 10.5732/cjc.009.10533. Chin J Cancer. 2010. PMID: 20426909 Free article.

8

Subdividing the M1 stage of liver metastasis for nasopharyngeal carcinoma to better predict metastatic survival.

Pan C, He N, Zhao M, Gu Y, Huang Z, Li W, Xia Y, Wu P. Pan C, et al. Among authors: xia y. Med Oncol. 2011 Dec;28(4):1349-55. doi: 10.1007/s12032-010-9643-8. Epub 2010 Sep 4. Med Oncol. 2011. PMID: 20820948

9

Involvement of difference in decrease of hemoglobin level in poor prognosis of Stage I and II nasopharyngeal carcinoma: implication in outcome of radiotherapy.

Gao J, Tao YL, Li G, Yi W, Xia YF. Gao J, et al. Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1471-8. doi: 10.1016/j.ijrobp.2011.05.009. Epub 2011 Jun 25. Int J Radiat Oncol Biol Phys. 2012. PMID: 21708429

10

Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma.

Li G, Gao J, Tao YL, Xu BQ, Tu ZW, Liu ZG, Zeng MS, Xia YF. Li G, et al. Chin J Cancer. 2012 Apr;31(4):197-206. doi: 10.5732/cjc.011.10283. Epub 2012 Jan 9. Chin J Cancer. 2012. PMID: 22237040 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,392 results

Search Page

Filters